Lv4
526 积分 2024-09-02 加入
Guidelines for the treatment of psoriasis with biologic agents in China （2021）
7天前
已完结
[2024 Chinese guidelines for the diagnosis and treatment of rheumatoid arthritis]
9天前
已完结
Next-Generation Anti-IL-17 Agents for Psoriatic Disease: A Pipeline Review
24天前
已完结
Upadacitinib for Treatment of Hyper-IgE Syndrome
1个月前
已完结
Efficacy and safety of oral JAK1 inhibitor upadacitinib monotherapy for papulopustular rosacea: A real-world study
1个月前
已完结
Oral tofacitinib, baricitinib and upadacitinib monotherapy for steroid‐resistant vitiligo: A prospective case series
1个月前
已完结
Treatment of refractory progressive vitiligo with oral upadacitinib and narrow‐band ultraviolet‐B: A case series
1个月前
已完结
Upadacitinib for refractory alopecia areata unresponsive to prior systemic therapies: A retrospective study
1个月前
已完结
Clinical response and safety of upadacitinib for alopecia areata: A retrospective study
1个月前
已完结
Upadacitinib outperforms dupilumab in restoring the fungal microbiome in atopic dermatitis
1个月前
已完结
皖公网安备34019202002308
